125 related articles for article (PubMed ID: 28683841)
1. Variable expression of molecular markers in juvenile nasopharyngeal angiofibroma.
Mishra A; Pandey A; Mishra SC
J Laryngol Otol; 2017 Sep; 131(9):752-759. PubMed ID: 28683841
[TBL] [Abstract][Full Text] [Related]
2. Current molecular profile of juvenile nasopharyngeal angiofibroma: First comprehensive study from India.
Pandey P; Mishra A; Tripathi AM; Verma V; Trivedi R; Singh HP; Kumar S; Patel B; Singh V; Pandey S; Pandey A; Mishra SC
Laryngoscope; 2017 Mar; 127(3):E100-E106. PubMed ID: 27577998
[TBL] [Abstract][Full Text] [Related]
3. Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George's Medical University, Lucknow, India.
Mishra A; Mishra SC
J Laryngol Otol; 2016 Apr; 130(4):363-8. PubMed ID: 26864451
[TBL] [Abstract][Full Text] [Related]
4. Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis.
Klockars T; Renkonen S; Leivo I; Hagström J; Mäkitie AA
Fam Cancer; 2010 Sep; 9(3):401-3. PubMed ID: 20229070
[TBL] [Abstract][Full Text] [Related]
5. Systems-level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas.
Renkonen S; Kankainen M; Hagström J; Haglund C; Monni O; Mäkitie AA
Laryngoscope; 2012 Dec; 122(12):2728-35. PubMed ID: 22965421
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of juvenile nasopharyngeal angiofibroma in brazilian patients.
Maniglia MP; Ribeiro ME; Costa NM; Jacomini ML; Carvalho TB; Molina FD; Piatto VB; Maniglia JV
Pediatr Hematol Oncol; 2013 Oct; 30(7):616-22. PubMed ID: 23802802
[TBL] [Abstract][Full Text] [Related]
7. Current status and clinical association of beta-catenin with juvenile nasopharyngeal angiofibroma.
Mishra A; Singh V; Verma V; Pandey S; Trivedi R; Singh HP; Kumar S; Dwivedi RC; Mishra SC
J Laryngol Otol; 2016 Oct; 130(10):907-913. PubMed ID: 27572281
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma.
Silveira SM; Custódio Domingues MA; Butugan O; Brentani MM; Rogatto SR
Head Neck; 2012 Apr; 34(4):485-92. PubMed ID: 22489321
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives on the origin theory of juvenile nasopharyngeal angiofibroma.
Li W; Ni Y; Lu H; Hu L; Wang D
Discov Med; 2019 Jun; 27(150):245-254. PubMed ID: 31421693
[TBL] [Abstract][Full Text] [Related]
10. Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing.
Jones JW; Usman S; New J; Holcomb A; Gunewardena S; Tawfik O; Hoover L; Bruegger D; Thomas SM
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):572-575. PubMed ID: 29634432
[TBL] [Abstract][Full Text] [Related]
11. Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour.
Valanzano R; Curia MC; Aceto G; Veschi S; De Lellis L; Catalano T; La Rocca G; Battista P; Cama A; Tonelli F; Mariani-Costantini R
Gut; 2005 Jul; 54(7):1046-7. PubMed ID: 15951557
[No Abstract] [Full Text] [Related]
12. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).
Ponti G; Losi L; Pellacani G; Rossi GB; Presutti L; Mattioli F; Villari D; Wannesson L; Alicandri Ciufelli M; Izzo P; De Rosa M; Marone P; Seidenari S
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):173-8. PubMed ID: 18227724
[TBL] [Abstract][Full Text] [Related]
13. The Genetic and Molecular Determinants of Juvenile Nasopharyngeal Angiofibroma: A Systematic Review.
Doody J; Adil EA; Trenor CC; Cunningham MJ
Ann Otol Rhinol Laryngol; 2019 Nov; 128(11):1061-1072. PubMed ID: 31148463
[TBL] [Abstract][Full Text] [Related]
14. [Comparative genomic hybridization as cytogenetic tumor diagnosis technique in juvenile angiofibroma].
Löwenheim H
HNO; 2003 Dec; 51(12):959-61. PubMed ID: 14647923
[No Abstract] [Full Text] [Related]
15. Genetic alterations in juvenile nasopharyngeal angiofibromas.
Coutinho-Camillo CM; Brentani MM; Nagai MA
Head Neck; 2008 Mar; 30(3):390-400. PubMed ID: 18228521
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.
Mishra A; Mishra SC; Tripathi AM; Pandey A
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2719-2726. PubMed ID: 30171340
[TBL] [Abstract][Full Text] [Related]
17. Expression of GSTM1 in angiofibromas.
Gautham K; Ogale SB; Shraddha RU; Ajay D
J Laryngol Otol; 2002 May; 116(5):352-4. PubMed ID: 12080991
[TBL] [Abstract][Full Text] [Related]
18. Bilateral, independent juvenile nasopharyngeal angiofibroma: case report.
Mørkenborg ML; Frendø M; Stavngaard T; Von Buchwald C
J Laryngol Otol; 2015 Oct; 129(10):1032-5. PubMed ID: 26314415
[TBL] [Abstract][Full Text] [Related]
19. Reassessing the Anatomic Origin of the Juvenile Nasopharyngeal Angiofibroma.
McKnight CD; Parmar HA; Watcharotone K; Mukherji SK
J Comput Assist Tomogr; 2017; 41(4):559-564. PubMed ID: 28632604
[TBL] [Abstract][Full Text] [Related]
20. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study.
Zhang PJ; Weber R; Liang HH; Pasha TL; LiVolsi VA
Arch Pathol Lab Med; 2003 Nov; 127(11):1480-4. PubMed ID: 14567719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
